Tamil Nadu: Cabinet approves land allocation for vaccine plant
The project entails production of viral vaccines such as TCA anti-measles vaccine, Japanese encephalitis and anti-sera at the PII, Coonoor. Land for the project will be transferred free of cost, an official statement said.
Tamil Nadu: The Union Cabinet on Wednesday approved the allotment of land to Pasteur Institute of India(PII) for setting up of new viral vaccine manufacturing unit at Coonoor in Tamil Nadu.
Also Read: GSK Pharma to invest Rs 1000 crore in Karnataka plant
The project entails production of viral vaccines such as TCA anti-measles vaccine, Japanese encephalitis and anti-sera at the PII, Coonoor. Land for the project will be transferred free of cost, an official statement said.
The allotment of land will encourage the production of life-saving vaccines for children and strengthen the vaccine security of the country. Most of these vaccines are at present imported.
The Pasteur Institute of India produces DPT vaccine and rabies vaccine for the Expanded Program on Immunization in India.
The institute was initially called the Pasteur Institute of Southern India. In 1907 it changed its name to the Pasteur Institute of India. In 1977 it became an autonomous body under the Ministry of Health and Family Welfare. The institute is named after the French scientist, Louis Pasteur.
Also Read: USFDA completes inspection at Caplin Point Lab’s sterile injectable facility in Tamil Nadu
Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd